Newsclip®: [Health] Genentech wins approval for immunotherapy drug - SFGate

"Federal regulators on Wednesday approved Genentech Inc.’s new therapy to treat bladder cancer, clearing the way for the South San Francisco drugmaker’s first agent that uses the body’s own immune system to fight the disease. Instead of attacking the disease itself, immunotherapy agents work on the immune system, typically by targeting how the cancer cells avoid being detected by the body’s natural defense mechanisms. “Tecentriq is a new medicine that can help work with the immune system to treat people with a type of bladder cancer that progressed after platinum-based chemotherapy,” said Dr. Sandra Horning, chief medical officer and head of global product development for Genentech, which is owned by Roche. The FDA approved Tecentriq to treat a common form of bladder cancer called urothelial carcinoma in patients with locally advanced or metastatic disease who have already been treated with the standard platinum-based chemotherapy. “This",

0 comments | 1 clip



Last clipped by

Hey! Thanks for checking out Newsclip®!

Click on this Trending Newsclip® Stack to read other top media reports on this topic.

Be sure to clip to your personal newspaper, like, comment and share!

Newsclip® is the leader of Social News Discovery®.

Welcome to the Newsclip® beta release!

Please enjoy the site during our beta phase and provide us with feedback on suggestions and issue details. Please remember that we are still in beta and there will be issues and site changes during this time.

Newsclip® the leading Online Social Newspaper, find trending articles through Social News Discovery®!

Invite Friends to Newsclip®

Invite your Facebook friends to follow you!

You can reopen the "Getting Started Tutorial" dialog from within the About menu in the top right corner.